These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
559 related articles for article (PubMed ID: 23350777)
21. Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma. Samis Zella MA; Wallocha M; Slotty PJ; Isik G; Hänggi D; Schroeteler J; Ewelt C; Steiger HJ; Sabel M Acta Neurochir (Wien); 2014 Feb; 156(2):313-23. PubMed ID: 24287680 [TBL] [Abstract][Full Text] [Related]
22. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. Stupp R; Dietrich PY; Ostermann Kraljevic S; Pica A; Maillard I; Maeder P; Meuli R; Janzer R; Pizzolato G; Miralbell R; Porchet F; Regli L; de Tribolet N; Mirimanoff RO; Leyvraz S J Clin Oncol; 2002 Mar; 20(5):1375-82. PubMed ID: 11870182 [TBL] [Abstract][Full Text] [Related]
23. A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients. Pan E; Mitchell SB; Tsai JS J Neurooncol; 2008 Jul; 88(3):353-7. PubMed ID: 18389176 [TBL] [Abstract][Full Text] [Related]
24. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis. Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891 [TBL] [Abstract][Full Text] [Related]
25. Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme. Smith KA; Ashby LS; Gonzalez LF; Brachman DG; Thomas T; Coons SW; Battaglia M; Scheck A J Neurosurg; 2008 Dec; 109 Suppl():106-17. PubMed ID: 19123896 [TBL] [Abstract][Full Text] [Related]
26. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology). Scoccianti S; Magrini SM; Ricardi U; Detti B; Buglione M; Sotti G; Krengli M; Maluta S; Parisi S; Bertoni F; Mantovani C; Tombolini V; De Renzis C; Lioce M; Fatigante L; Fusco V; Muto P; Berti F; Rubino G; Cipressi S; Fariselli L; Lupattelli M; Santoni R; Pirtoli L; Biti G Neurosurgery; 2010 Aug; 67(2):446-58. PubMed ID: 20644432 [TBL] [Abstract][Full Text] [Related]
28. A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma. Shenouda G; Souhami L; Petrecca K; Owen S; Panet-Raymond V; Guiot MC; Corredor AG; Abdulkarim B Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):487-494. PubMed ID: 28011051 [TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme. Darakchiev BJ; Albright RE; Breneman JC; Warnick RE J Neurosurg; 2008 Feb; 108(2):236-42. PubMed ID: 18240917 [TBL] [Abstract][Full Text] [Related]
30. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study. Illic R; Somma T; Savic D; Frio F; Milicevic M; Solari D; Nikitovic M; Lavrnic S; Raicevic S; Milosevic S; Cavallo LM; Cappabianca P; Grujicic D World Neurosurg; 2017 Aug; 104():581-588. PubMed ID: 28522381 [TBL] [Abstract][Full Text] [Related]
31. Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: prospective, observational, multicenter study on 92 cases. Duntze J; Litré CF; Eap C; Théret E; Debreuve A; Jovenin N; Lechapt-Zalcman E; Metellus P; Colin P; Guillamo JS; Emery E; Menei P; Rousseaux P; Peruzzi P Ann Surg Oncol; 2013 Jun; 20(6):2065-72. PubMed ID: 23212763 [TBL] [Abstract][Full Text] [Related]
32. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience. Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985 [TBL] [Abstract][Full Text] [Related]
33. Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide. Weiler M; Hartmann C; Wiewrodt D; Herrlinger U; Gorlia T; Bähr O; Meyermann R; Bamberg M; Tatagiba M; von Deimling A; Weller M; Wick W Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):670-6. PubMed ID: 19836157 [TBL] [Abstract][Full Text] [Related]
34. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Minniti G; Lanzetta G; Scaringi C; Caporello P; Salvati M; Arcella A; De Sanctis V; Giangaspero F; Enrici RM Int J Radiat Oncol Biol Phys; 2012 May; 83(1):93-9. PubMed ID: 22079725 [TBL] [Abstract][Full Text] [Related]
35. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651 [TBL] [Abstract][Full Text] [Related]
36. Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Cohen MH; Johnson JR; Pazdur R Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6767-71. PubMed ID: 16203762 [TBL] [Abstract][Full Text] [Related]
37. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. Minniti G; De Sanctis V; Muni R; Rasio D; Lanzetta G; Bozzao A; Osti MF; Salvati M; Valeriani M; Cantore GP; Maurizi Enrici R J Neurooncol; 2009 Jan; 91(1):95-100. PubMed ID: 18758912 [TBL] [Abstract][Full Text] [Related]
38. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. Stupp R; Taillibert S; Kanner AA; Kesari S; Steinberg DM; Toms SA; Taylor LP; Lieberman F; Silvani A; Fink KL; Barnett GH; Zhu JJ; Henson JW; Engelhard HH; Chen TC; Tran DD; Sroubek J; Tran ND; Hottinger AF; Landolfi J; Desai R; Caroli M; Kew Y; Honnorat J; Idbaih A; Kirson ED; Weinberg U; Palti Y; Hegi ME; Ram Z JAMA; 2015 Dec; 314(23):2535-43. PubMed ID: 26670971 [TBL] [Abstract][Full Text] [Related]
39. Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution. Joo JD; Kim H; Kim YH; Han JH; Kim CY J Korean Med Sci; 2015 Nov; 30(11):1597-603. PubMed ID: 26539003 [TBL] [Abstract][Full Text] [Related]
40. Polymeric drug delivery for the treatment of glioblastoma. Wait SD; Prabhu RS; Burri SH; Atkins TG; Asher AL Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii9-ii23. PubMed ID: 25746091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]